-+ 0.00%
-+ 0.00%
-+ 0.00%

Jaguar Health wins FDA fee waivers for Mytesi, Canalevia for fiscal 2027

PUBT·09/22/2026 13:06:10
Listen to the news
Jaguar Health wins FDA fee waivers for Mytesi, Canalevia for fiscal 2027
  • FDA granted Jaguar Health PDUFA fee waiver for Mytesi for fiscal 2027, lowering expected regulatory user-fee costs.
  • FDA’s Center for Veterinary Medicine also waived the fiscal 2027 fee for Canalevia-CA1, its conditionally approved canine diarrhea drug.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jaguar Health Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202609220905ACCESSWRNAPR_____1225091) on September 22, 2026, and is solely responsible for the information contained therein.